Verdad Advisers »

Relmada Therapeutics shares owned by Verdad Advisers

Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Verdad Advisers from 13F filings

Historical chart of Verdad Advisers investment in Relmada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relmada Therapeutics held by Verdad Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relmada Therapeutics by Verdad Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $328k 47k 6.96

More positions owned by Verdad Advisers

Belite Bio Sponsored Ads (BLTE)
State Street Corporation (STT)
Autohome Sp Ads Rp Cl A (ATHM)
Revolution Medicines (RVMD)
Zymeworks Del (ZYME)
Cal Maine Foods Com New (CALM)
Zoom Communications Cl A (ZM)
California Res Corp Com Stock (CRC)
Tenax Therapeutics Com New (TENX)
ACADIA Pharmaceuticals (ACAD)
Par Pac Holdings Com New (PARR)
Johnson & Johnson (JNJ)
Micron Technology (MU)
Nurix Therapeutics (NRIX)
Comcast Corp Cl A (CMCSA)

View all positions for Verdad Advisers

Top funds holding Relmada Therapeutics

Henderson Group
Squadron Capital Management
VR Adviser
Adage Capital Partners GP
OrbiMed Advisors
Marshall Wace
Millennium Management
Vanguard Capital Management
RA Capital Management
Ikarian Capital
Driehaus Capital Management
Ameriprise Financial
Polar Capital Holdings
Susquehanna International
BlackRock

View all funds holding Relmada Therapeutics